Anaplastic Astrocytoma - 215 Studies Found

Recruiting : Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
:
  • Recurrent Glioblastoma Multiforme
  • Progressive Glioblastoma Multiforme
  • Glioblastoma
  • Astrocytoma

: 2006-06-06
:
  • Drug: Temozolomide Temozolomid
Recruiting : TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
:
  • Brain Tumor
  • Astrocytoma
  • Astroglioma
  • Drug: TG02 Phase I: Two treatm
Recruiting : Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children
:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma

: 2016-08-24
: Drug: Cabozantinib Subjects will receive Cabozantinib
Completed : Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
:
  • Glioblastoma
  • Anaplastic Astrocytoma

: 2011-12-24
:
  • Drug: Temozolomide 100 mg/m2 p
Terminated : Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
:
  • Glioblastoma Multiforme (WHO Grade IV)
  • Anaplastic Astrocytoma (
    : 2006-01-04
    :
    • Drug: 06Benzylguanine 120 mg/m
Terminated : A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic
    : 2010-10-15
    :
    • Drug: PD 0332991 (pre-surgery)

Completed : AMG 595 First-in-Human in Recurrent Gliomas
:
  • Advanced Malignant Glioma
  • Anaplastic Astrocytomas
  • : 2011-09-29
    : Drug: AMG 595 AMG 595 is an antibody drug conjugate that binds to EGFRvIII.
<<< Previous | Next >>>